Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

NeuroImmunoModulation

Volumn 4, Issue 3, 1997, Pages 134-153

  Clauw, Daniel J ^a   Chroitsos, George P ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Chronic fatigue syndrome; Fatigue; Fibromyalgia; Pain

Indexed keywords

CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; NEUROHORMONE; NEUROPEPTIDE; SEX HORMONE; SOMATOMEDIN C; SUBSTANCE P; THYROID HORMONE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CLINICAL FEATURE; FIBROMYALGIA; GENETIC PREDISPOSITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE SYSTEM; NEUROENDOCRINOLOGY; NEUROSIS; NOCICEPTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 13144306085     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097332     Document Type: Article

References (196)

1. McKenzie R, Straus SE: Chronic fatigue syndrome, Adv Intern Med 1995:40:1 19-153.
2. Straus SE: Studies of herpesvirus infection in chronic fatigue syndrome, Ciba Found Symp 1993;173:132-145.
3. Yunus MB: Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation, J Rheumatol 1992;19:846-850.
4. Hadler NM: Is fibromyalgia a useful diagnostic label? Clevc Clin J Med 1996:63:85-87.
5. Manu P, Lane TJ, Matthews DA: Chronic fatigue and chronic fatigue syndrome: Clinical epidemiology and actiological classification, Ciba Found Symp 1993:173:23-42.
6. Lane TJ, Manu P, Matthews DA: Depression and somatization in the chronic fatigue syndrome, Am J Med 1991:91:335-344.
7. Bohr T: Problems with myofascial pain syndrome and fibromvalgia syndrome, Neurology 1996:46:593-597.
8. Wolfe F, Sniythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia, Report of the Multicenter Criteria Committee, Arthritis Rheum 1990:33:160-172.
9. Wolle F, Ross K, Anderson J, Russel IJ, Heben L: The prevalence and characteristics of fibromyalgia in the general population, Arthritis Rheum 1995:38:19-28.
10. Cohen ML, Quintner JL: Fibromyalgia syndrome, a problem of tautology, Lancet 1993: 342:906-909.
11. Granges G, Littlejohn G: Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndrome, and in patients with fibromyalgia syndrome, Arthritis Rheum 1993:36:642-646.
12. Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H: Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls, Arch Phys Med Re-habil 1992:73:814-818.
13. Wolfe F, Ross K, Anderson J, Russell 1J: Aspects of fibromyalgia in the general population: Sex, pain threshold, and fibromyalgia symptoms, J Rheumatol 1995:22:151-156.
14. Urrows S, Affleck G, Tennen 11, Higgins P: Unique clinical and psychological correlates of fibromyalgia lender points and joint tenderness in rheumatoid arthritis, Arthritis Rheum 1994:37:1513-1520.
15. Silman A, Scholium J, Croft P: The epidemiology of tender point counts in the general population, Arthritis Rheum 1993;36(95):59.
16. Granges G, Littlejohn GO: A comparative study of clinical signs in fibromvalgia/fibrositis syndrome, healthy and exercising subjects, J Rheumatol 1993:20:344-351.
17. Jacobsen S, Brcdkjacr SR: The prevalence of fibromyalgia and widespread chronic musculoskeletal pain in the genera! population, Scand J Rheumatol 1992:21:261-263.
18. IS Raspe H, Baumgartner C, Wolfe F: The prevalence of fibromyalgia in a rural German community: How much difference do different criteria make? Arthritis Rheum 1993;36(95):58.
19. Yunus MB: Fibromyalgia syndrome: New research on an old malady, B.VIJ 1989:298:474-475.
20. Clauw DJ: Fibromyalgia: More than just a musculoskeletal disease, Am Fam Physician 1995:52:843-851.
21. Waylonis GW, Heck W: Fibromyalgia syndrome, New Associations, Am J Phys Med Rchabil 1992:71:343-348.
22. Hyams KC, Wignall FS, Roswell R: War syndromes and their evaluation: From the US Civil War to the Persian Gulf War, Ann Intent Med 1996:125:398-405.
23. Goldenberg DL: Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome, CurrOpin Rheumatol 1991:3:247-258.
24. Russo J, Raton W, Sullivan M, Clark M, Buch-wald D: Severity of somatization and its relationship to psychiatric disorders and personality, Psychosomatics 1994:35:546-556.
25. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PH Jr, Schlesinger L: Comorbidity of fibromyalgia with medical and psychiatric disorders, Ant J Med 1992:92:363-367.
26. Waylonis GW, Perkins RII: Post-traumatic fibromyalgia, A long-term follow-up, Am J Phys Med Rchabil 1994:73:403-412.
27. Greenfield S, Fitzcharlcs MA, Esdaile JM: Reactive fibromyalgia syndrome, Arthritis Rheum 1992;35:678-681.
28. Fukuda K, Wilson L, Dobbins J: A communi-ty-bascd study of unexplained prolonged and chronic fatiguing illness in a rural area of Michigan, J Psychiatr Res, in press.
29. Buchwatd D, Untali P, Untali J, Kith P, Pearl-man T, Komaroff AL: Chronic fatigue and the chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system, Ann Intern Med 1995;123:81-88.
30. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komarofi A: Chronic fatigue syndrome: A comprehensive approach to its definition and study, Ann Intern Med 1994:121:953-959.
31. Komaroft AL: Clinical presentation of chronic fatigue syndrome, Ciba Found Syntp 1993; 173: 43-61.
32. Jason I., Taylor R, Wagner L, Holden J, Ferrari J, Plioplys A, Lipkin D, Papernik M: A pilot study estimating rates of chronic fatigue syndrome Iront a community based sample, J Psychiatr Res, in press.
33. Ablashi DV: Viral studies of chronic fatigue syndrome, Clin Infect Dis 1994;18(suppl I): S130-S133.
34. Kiccolt-Glascr JK, Caeioppo JT, Malarkev WB, Glaser R: Acute psychological stressors and short-term immune changes: What, why for « hont, and to what extent? Psvehosom Med 1992:54:680-685.
35. Stein M, Keller S, Schleifer S: Stress and immu-nomodulalion: The role of depression and neuroendocrine function, J Immunol 1985:135: 827s-833s.
36. Katon W, Lin E, von Korfi M, Russo J, Lipscomb P, Bush T: Somatization: A spectrum of severity, Am J Psychiatry 1991:148:34-40.
37. Escobar JI, Burnham MA, Kamo M, Forsythe A, GoldingJM: Somatization in the community, Arch Gen Psychiatry 1987:44:713-718.
38. Quintncr JL: Somatisation disorder: A major public health issue, Med J Aust 1995:163:558-559.
39. Bell IR: Somatization disorder: Health care costs in the decade of the brain, Biol Psychiatry 1994:35:81-83.
40. Barsky AJ, Borus JF: Somatization and medi-calizalion in the era of managed care, JAMA 1995:274:1931-1934.
41. Kirmayer LJ, Robbins JM: Three forms of somatization in primary care: Prevalence, cooccurrence, and sociodemographic characteristics, J Nerv Ment Dis 1991:179:647-655.
42. Kroenke K, Mangclsdorf AD: Common symptoms in primary care: Incidence, evaluation, therapy, and outcome, Am J Med 1989;86: 262-266.
43. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruv FV III, Brody D: Physical symptoms in primary care, Predictors of psychiatric disorders and functional impairment, Arch Fam Med 1994;3:774-779.
44. Smith GR, Monson R, Rav D: Patients with multiple unexplained symptoms: Their characteristics, functional health, and health care utilization, Arch Intern Med 1986;146:69-72.
45. Buchwatd D, Garrity D: Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities, Arch Intern Med 1994;154:2049-2053.
46. NIH Workshop Panel: The Persian Gulf experience and health, JAMA 1994;272:391-396.
47. Bridges AJ, Conley C, Wang G, Burns DF., Vasey FB: A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease, Ann Intern Med 1993:118:929-936.
48. Gothc CJ, Molin C, Nilsson CG: The environmental somatization syndrome, Psychosomatics 1995:36:1-11.
49. Chester AC, Levine PH: Concurrent sick building syndrome and chronic fatigue syndrome: Epidemic neuromyasthenia revisited, Clin Infect Dis 1994:l8(suppl l):S43-S48.
50. Modolfsky H, Scarisbrick P, England R, Smythc H: Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome" and healthy subjects, Psv-chosom Med 1975;37:341-351.
51. Manu P, Lane TJ, Matthews DA, Castriotta RJ, Watson RK, Abeles M: Alpha-delta sleep in patients with a chief complaint of chronic fatigue, South Med J 1994:87:465-470.
52. Reynolds WJ, Moldofsky H, Saskin P, Lue FA: The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia, J Rheumatol 1991;18:452-454.
53. Alvarez Lario B, Teran J, Alonso JL, Alegre J, Arroyo I, Viejo JL: Lack of association between fibromyalgia and sleep apnoca syndrome, Ann Rheum Dis 1992:51:108-111.
54. Simms RW, Goldenberg DL: Symptoms mimicking neurologic disorders in fibromyalgia syndrome, J Rheumatol 1988:15:1271-1273.
55. Johnson SK, DeLuca J, Fiedler N, Natclson BH: Cognitive functioning of patients with chronic fatigue syndrome, Clin Infecí Dis 1994:18(suppl 1):S84-S85.
56. McDonald E, Cope II, David A: Cognitive impairment in patients with chronic fatigue: A preliminary study, J Neurol Neurosurg Psychiatry’ 1993:56:812-815.
57. Slotkoff AT, Clauw DJ: Fibromyalgia: When thinking is impaired, J Musculoskeletal Med 1996;13:32-36.
58. Cope H, Pcmct A, Kendall B, David A: Cognitive functioning and magnetic resonance imaging in chronic fatigue, Br J Psychiatry 1995: 167:86-94.
59. Cleveland CH Jr, Fisher RH, Breslcl EP, Esin-liart JD, Metzger WJ: Chronic rhinitis: An undcrrecognized association with fibromyalgia, Allergy Proc 1992:13:263-267.
60. Clauw DJ, Gaumond E, Radulovic D, Pandiri P, Ali M, Foong S, Baraniuk J: The role of true IgE mediated allergic mechanisms in the allergic symptoms of fibromyalgia, Arthritis Rheum 1996:39(55):R20.
61. Rosenhall U, Johansson G, Orndahl G: Eye motility dysfunction in primary fibromyalgia with dysesthesia, Scand J Rchabil Med 1987; 19:139-145.
62. Gcrster JC, Hadj-Djilani A: Hearing and vestibular abnormalities in primary fibrositis syndrome, J Rheumatol 1984;11:678-680.
63. Dworkin SF, Massoth DL: Temporomandibular disorders and chronic pain: Disease or illness? J Prosthct Dent 1994:72:29-38.
64. Bonafede RP, Downey DC, Bennett RM: An association of fibromyalgia with primary Sjogren’s syndrome: A prospective study of 72 patients, J Rheumatol 1995;22:133-136.
65. Mukcrji B, Mukcrji V, Alpcrt MA, Selukar R: The prevalence of rheumatologic disorders in patients with chest pain and angtographically normal coronary arteries, Angiology 1995:46: 425-430.
66. Lurie M, Caidahl K, Johansson G, Bake B: Respiratory function in chronic primary fibro-mvalgia, Scand J Rehabil Med 1990:22:151-155.
67. Clauw DJ, Keefe B, Maher K, Benjamin SB: Comparison of esophageal manometry and results of visceral nociceptive testing in individuals with fibromyalgia and noncardiac chest pain, Arthritis Rheum 1996:39(99):S276.
68. Pellegrino MJ, Van Fossen D, Gordon C, Ryan JM, Waylonis GW: Prevalence of mitral valve prolapse in primary fibromyalgia: A pilot investigation, Arch Phys Med Rehabil 1989:70; 541-543.
69. Rowe PC, Bou-Holaigah I, Kan JS, Calkins H: Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995: 345:623-624.
70. Wallace DJ: Genitourinary manifestations of fibrositis: An increased association with the female urethral syndrome, J Rheumatol 1990; 17:238-239.
71. Koziol JA, Clark DC, Gilles RF, Tan EM: The natural history of interstitial cystitis, J Urol 1993:149:465-469.
72. Friedrich EG: Vulvar vestibulitis syndrome, J Reprod Med 1987:32:110-114.
73. Yunus MB, Allies TA, Aldag JC, Masi AT: Relationship of clinical features with psychological status in primary fibromyalgia, Arthritis Rheum 1991:34:15-21.
74. Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT: Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: A blind comparison of DSM-III diagnoses, Am J Psychiatry 1991; 148:1721-1726.
75. Boissevain MD, McCain GA: Toward an integrated understanding of fibromyalgia syndrome, 11, Psychological and phenomenological aspects, Pain 1991:45:239-248.
76. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D: Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: A prospective study in the primary carc setting, Am J Psychiatry 1996:153:1050-1059.
77. Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-AlexanderM, Martin MY, Alberts KR: Psychiatric diagnoses in patients with fibromyalgia are related to health carc-seeking behavior rather than to illness, Arthritis Rheum 1996:39:436-445.
78. Hudson JI, Hudson MS, Pliner LF, Goldcn-berg DL, Pope HGJ: Fibromyalgia and major affective disorder: A controlled phenomenology and family history study, Am J Psychiatry 1985;142:441-446.
79. Cohen S, Rodriquez MS: Pathways linking affective disturbances and physical disorders, Health Psychol 1995;14:374-380.
80. Nielson WR, Walker C, McCain GA: Cognitive behavioral treatment of fibromyalgia syndrome: Preliminary findings, J Rheumatol 1992;19:98-103.
81. White KP, Nielson WR: Cognitive behavioral treatment of fibromyalgia syndrome: A follow-up assessment, J Rheumatol 1995:22:717-721.
82. Speckens AE, van Hemcrt AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG: Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial, BMJ 1995:311:1328-1332.
83. Stormorken H, Brosstad F: Fibromyalgia: Family clustering and sensory urgency with early onset indicate genetic predisposition and thus a True disease, Scand J Rheumatol 1992: 21:207.
84. Pellegrino MJ, Waylonis GW, Sommer A: Familial occurrence of primary fibromyalgia, Arch PhysRehabil 1989:70:61-63.
85. Messingcr HB, Spicrings ELH, Vincent AJP, Lebbink J: Headache and family history, Cephalgia 1991:11:13-18.
86. Kendler KS, Walters EE, Tructi KR, Heath AC, Ncalc MC, Martin NG: A twin-family study of self-report symptoms of panic-phobia and somatization, Bchav Genet 1995:25:499-515.
87. Kendler KS, Eaves LI, Walters EE, Neale MC, Heath AC, Kessler RC: The identification and validation of distinct depressive syndromes in a population-based sample of female twins, Arch Gen Psychiatry 1996:53:391-399.
88. Waylonis GW, Perkins RH: Post-traumatic fibromyalgia, A long-term follow-up, Am J Phys Med Rehabil 1994:73:403-412.
89. Goldenberg D: Fibromyalgia and its relation to chronic fatigue syndrome, viral illness, and immune abnormalities, J Rheumatol 1989:19(8): 91-93.
90. Culclasurc TF, Enzenauer RJ, West SG: Post-traumatic stress disorder presenting as fibromyalgia, AmJ Med 1993:94:548-549.
91. Hazlett RL, Haynes SN: Fibromyalgia: A timc-serics analysis of the strcssor-physical symptoms association, J Bchav Med 1992:15:541-558.
92. Dailey PA, Bishop GD, Russell IJ, Fletcher EM: Psychological stress and the fibrositis/ fibromyalgia syndrome, J Rheumatol 1990:17: 1380-1385.
93. Salit I: Precipitating Events in CFS, American Association of Chronic Fatigue Syndrome Proceedings, Fort Lauderdale, 1994.
94. Bcnglsson A, Hcnrickson KG, Larsson J: Muscle biopsy in fibromyalgia, Scand J Rheumatol 1986;15:1-6.
95. Bcnglsson A, Hcnrickson KG, Larsson J: Reduced high energy phosphate levels in the painful muscles of patients with primary fibromyalgia, Arthritis Rheum 1986:29:817-821.
96. 31P magnetic resonance spectroscopy of skeletal muscle in patients with fibromyalgia, J Rheumatol 1992; 19:1600-1603.
97. JIP magnetic resonance spectroscopy (MRS) of tender points in patients with primary' fibromyalgia syndrome, Rheumatol Int 1991:11:51-54.
98. Simms RW, Roy S, Skrinar G, Ilrovat M, Anderson JJ, Kimmels A, Zerbini CF, DeLu-ca C, Joles, F: Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism, Arthritis Rheum 1994:37:794-800.
99. Krupp L, Mendelson W, Friedman R: An overview of chronic fatigue syndrome, J Clin Psychiatry 1991:52:10:403-410.
100. Barker E, Fujimura SF, Fadcm MB, Landay AL, Levy JA: Immunologic abnormalities associated w ith chronic fatigue syndrome, Clin Infect Dis 1994:18(suppl 1):S136-S141.
101. Ojo-Amaizc EA, Conley E.I, Peter JB: Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome, Clin Infect Dis 1994: 18(suppl I):S157-S159.
102. Morrison L, Behan W, Behan P: Changes in natural killer cell phenotype in patients with post viral fatigue syndrome, Clin Exp Immunol 1991:83:441-446.
103. Caro XJ, Ojo-Amaize EA, Agopian MS, Peter JB: Natural killer cell function in primary fibrositis (fibromyalgia) syndrome, Arthritis Rheum 1993;36(98):D114.
104. Rasmussen A, Nielsen H, Andersen V, Bar-ington T, Bcndlzen K, Hansen M, Nielsen L, Pedersen B, Wiik A: Chronic fatigue syndrome-a controlled cross sectional study, J Rheumatol 1994:21:1527-1532.
105. Bates DW, Buchwnld D, Lee J, Kith P, Doolittle T, Rutherford C, Churchill WH, Schur PH, Wcncr M, Wybcnga D: Clinical laboratory test findings in patients with chronic fatigue syndrome, Arch Intern Med 1995:155: 97-103.
106. Dekaris D, Sabionccllo A, Mazuran R, Rabatic S, Svoboda-Bcusan I, Racunica N, Tomasic J: Multiple changes of immunologic parameters in prisoners of war, JAMA 1993:270:5: 595-599.
107. Buchwald D, Komarolt AL: Review of laboratory findings for patients with chronic fatigue syndrome, Rev Infect Dis 1991:13(51): S12-S18.
108. Irwin M: Stress-induced immune suppression: Role of brain corticotropin releasing hormone and autonomic nervous system mechanisms, Adv Ncuroimmunol 1994:4: 29-47.
109. Gatti G, Meluzzi A, Francesetli G, Masera R, Sartori M, Maina L, Carignola R, Angeli A: Psychocmotional, cognitive, chronocndo-crine, and immune responses to a survival performance in an African desert, Ann NY Acad Sci 1994:650:251-256.
110. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune mediated inflammation, N Engl J Med 1995:332:1351-1362.
111. Dhabhar FS, Miller AH, McEwen B, Spencer RL: Stress-induced changes in blood leukocyte distribution, J Immunol 1969; 157:1638-1644.
112. Schafer M, Mousa SA, Zhang Q, Carter L, Stein C: Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia, Proc Natl Acad Sci USA 1996:93:6096-6100.
113. Larsen PJ, Jessop D, Patel H, Lighlman SL, Chowdrey HS: Substance P inhibits the release of anterior pituitary adrcnocorticotro-pin via a central mechanism involving corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus, J Neuroendocrinol 1993;5:99-105.
114. Cultnan J, Tschope C, Jost N, Itoi K, Unger T: Substance P and neurokinin A induced dcsensitization to cardiovascular and behavioral effects: Evidence for the involvement of different tachykinin receptors, Brain Res 1993;625:75-83.
115. Jessop DS, Chowdrey HS, Larsen PJ, Lighlman S: Substance P: Multifunctional peptide in the hypothalamic-pituitary system? J Endocrinol 1992:132:331-337.
116. Gold PW, Goodwin F, Chrousos GP: Clinical and biochemical manifestations of depression: Relationship to the neurobiology of stress, I, N Engl J Med 1988:319:348-353.
117. Chrousos GP, Gold PW: The concepts of stress and stress system disorders, Overview of physical and behavioral homeostasis, JAMA 1992:267:1244-1252.
118. Mcaney MJ, Bh3tnagar S, Laroeque S, McCormick C, Shanks N, Sharma S, Sntythe J, Viau V, Plotsky PM: Individual differences in the hypothalamic-pituilary-adrenal stress response and the hypothalamic CRF system, Ann N Y Acad Sci I 993:697:70-85.
119. Romero LM, Plotsky PM, Sapolsky RM: Patterns of adrcnoconicotropin sccrctagogue release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport, Endocrinology 1993:132:199-204.
120. Viau V, Sharma S, Plosky PM, Meaney MJ: Increased plasma ACTH responses to stress in nonhandled compared with handled rats require basal levels of corticosterone and are associated with increased levels of ACTH sc-cretagogucs in the median eminence, J Ncu-rosci 1993;13:1097-1105.
121. Slein-Bchrcns BA, Lin WJ, Sapolsky RM: Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus, J Ncurochcm 1994:63:596-602.
122. Sapolsky RM: Why stress is bad for your brain, Science 1996;273:749-750.
123. Stein-Behrcns B, Mattson MP, Chang I, Ych M, Sapolsky R: Stress exacerbates neuron loss and cytoskelctal pathology in the hippocampus, J Neurosci 1994:14:5373-5380.
124. Glaser R, Lafuse WP, Bonneau RH, Atkinson C, Kiccolt-Glascr JK: Stress-associated modulation of proto-oncogene expression in human peripheral blood leukocytes, Bchav Ncu-rosci 1993:107:525-529.
125. Walling MK, O'hara MW, Reiter RC, Milbum AK, Lilly G, Vincent SD: Abuse history and chronic pain in women, II, A multivariate analysis of abuse and psychological morbidity, Obsiel Gynecol 1994:84:200-206.
126. Spaccarelli S: Stress, appraisal, and coping in child sexual abuse: A theoretical and empirical review, Psychol Bull 1994:116:340-362.
127. Bendixen M, Muus KM, Schei B: The impact of child sexual abuse-a study of a random sample of Norwegian students, Child Abuse Negl 1994:18:837-847.
128. Sternberg EM: Hyperimmune fatigue syndromes: Diseases of the stress response? J Rheumatol 1993:20:418-421.
129. Brown MR, Fisher LA, Spicss J, Rivicr C, Rivier J, Vale W: Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism, Endocrinology 1982; 111:928-931.
130. Sutton RE, Koob GF, Le Moal M, Rivicr J, Vale W: Corticotropin releasing factor produces behavioral activation in rats, Nature 1982:297:331-333.
131. Bearn J, Allain T, Coskcran P, Munro N, Butler J, McGregor A, Wessely S: Neuroendocrine responses to d-fenfiuraminc and insulin-induced hypoglycemia in chronic fatigue syndrome, Biol Psychiatry 1995:37:245-252.
132. Gricp EN, Boersma JW, de Kloet ER: Altered reactivity of the hypolhalamic-pituitary-adre-nal axis in the primary fibromyalgia syndrome, J Rheumatol 1993:20:469-474.
133. CrofTord LJ, Pillemer SR, Kalogeras KT, Cash JM, Michclson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypolhalamic-pituitary-adrcnal axis perturbations in patients with fibromyalgia, Arthritis Rheum 1994:37:1583-1592.
134. McCain GA, Tilbc KS: Diurnal hormonal variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis, J Rheumatol 1989:16(195): 154-157.
135. van Dendercn JC, Boersma JW, Zeinstra P, Hollander AP, van Nccrbos BR: Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): Is PFS a disorder of neuroendocrine reactivity? ScandJ Rheumatol 1992:21:35-37.
136. Yehuda R, Teicher MH, Levengood RA, Trcstman RL, Sievcr LJ: Circadian regulation of basal cortisol levels in posltraumatic stress disorder, Ann N Y Acad Sci 1994:746:378-380.
137. Mason JW, Gillcr EL, Kosten TR, Oslroff RB, Podd L: Urinary frec-cortisol levels in posttraumatic stress disorder patients, J Nerv Mental Dis 1986:174:145-149.
138. Vandcrpool J, Rosenthal N, Chrousos GP, WherT, Gold PW: Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder, J Clin Endocrinol Metab 1991:72:1382-1387.
139. Anisman H, Zacharko R: Depression as a consequence of inadequate neurochcmica! adaptation in response to stressors, Br J Psychiatry Suppl 1992;15:36-43.
140. Bcnnctt RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome, A possible link between sleep and muscle pain, Arthritis Rheum 1992:35:1113-1116.
141. Russell IJ, Vipraio GA, Michalek JE, Lopel, YG: Insulin-like growth factor in fibromyalgia, rheumatoid arthritis, osteoarthritis, and healthy normal controls: Roles of diagnosis, age, sex, and ethnic origin, Arthritis Rheum 1992;35(98):B263.
142. Bennett RM, Cook DM, Clark SR, Campbell SM, Burckhardt CS: Low somatomedin-C in fibromyalgia patients: An analysis of clinical specificity and pituitary/hepatic responses, Arthritis Rheum 1993;36(95):62.
143. Dicguez C, Page MD, Scanlon MF: Growth hormone ncurorcgulation and its alterations in disease states, Clin Endocrinol 1988:28: 109-143.
144. Rivier C, Vale W: Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat, Endocrinology 1985.117: 2478-2482.
145. Burguera B, Muruais C, Pcnalva A, Dieguez C: Dual and selective actions of glucocorticoid upon basal and stimulated growth hormone release in man, Ncuroendocrinology 1990:51:51-58.
146. Stratakis CA, Chrousos GP, Gold PW: Neu-rocndocrinology of stress: Implications for growth and development, Horm Res 1995:43: 162-167.
147. Neeck G, Riedel W: Thyroid function in patients with fibromyalgia syndrome, J Rheumatol 1992:19:1120-1122.
148. Sorensen J, Benglsson A, Backman E, Henriksson KG, Benglsson M: Pain analysis in patients with fibromyalgia, Eficcts of intravenous morphine, lidocaine, and Letamine, ScandJ Rheumatol 1995:24:360-365.
149. Whitehead WE, Holtkottcr B, Enek P: Tolerance for rectosigmoid distension in irritable bowel syndrome, Gastroenterology 1990:98: 1187-1192.
150. Corcmans G, Tack J, Vantrappen G, Janssens J, Annese V: Is the irritable bowel really irritable? Ila! J Gastroenterol 1991;23:39-40.
151. Lembo T, Munakata J, Mcrtz H, Naizi N, Kodner A, Nikas V, Mayer EA: Evidence for hypersensitivity of lumbar splanchnic afférents in irritable bowel syndrome, Gastroenterology 1994;107:1686-1696.
152. Cook IJ, van Eeden A, Collins SM: Patients with irritable bowel syndrome have greater pain tolerance than normal subjects, Gastroenterology 1987;93:727-733.
153. Nicolodi M, Sicuteri F, Sicuteri R: Noci-auto-nomic-affective automatism, the physio-pathological essence of hcmicrania, The serotonin theory as a guiding principle in the labyrinth of interpretations, Ann Ital Med Int 1992;7:7S-22S.
154. Dougherty PM, Paleeck J, Zorn S, Willis WD: Combined application of excitatory’ amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons, Brain Res Brain Res Rev-1993; 18:227-246.
155. Mjellem-Joly N, Lund A, Berge OG, Hole K: Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test, Pain 1992;51:195-198.
156. Woolf CJ, Thompson SWN: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain 1991;44:293-299.
157. Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects, Pain 1997;70:41-51.
158. Noel M, Ncmcroff CB: The role of non-opioid peptides in pain, Pain Headache 1987;9:194-212.
159. Russell IJ, Michalck JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipraminc uptake receptor density and serum serotonin levels in patients with fibro-myalgia/fibrositis syndrome, J Rheumatol 1992;19:104-109.
160. Russell IJ, Vaeroy H, Javors M, Nybcrg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrosilis syndrome and rheumatoid arthritis, Arthritis Rheum 1992; 35:550-556.
161. Russel IJ, Vacrcoy H, Javors M, Nybcrg F: Cerebrospinal fluid biogenic amines in fibrositis/fibroinyalgia syndrome, Arthritis Rheum 1990;9(suppl 33):S55.
162. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study, J Rheumatol 1992:19:90-94.
163. Houvenagel E, Forzy G, Cortei B, Vincent G: 5 hydroxy indole acetic acid in cerebrospinal fluid in fibromyalgia, Arthritis Rheum 1990; 9(suppl 33):S55.
164. Gulley L, Nemeroft C: The ncurobiological basis of mixed depression-anxiety states, J Clin Psychiatry 1993;54:16-19.
165. Howland R, Thase M: Biological studies of dysthymia, Biol Psychiatry 1991:30:283-304.
166. Ferrar MD, Odink J, Bos KD: Neurocxcitatory plasma amino acids arc elevated in migraine, Neurology 1990:40:1582-1586.
167. Godfrey RG: A guide to the understanding and use of tricyclic antidcprcssants in the overall management of fibromyalgia and other chronic pain syndromes, Arch Intern Med 1996;156:1047-1052.
168. Barnes PJ, Baraniuk JN, Belvisi MG: State of the art: Neuropeptides in the respiratory tract, Am Rev Respir Dis 1991:144:1187-1198.
169. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalck JE, Lopez YM, MacKillip F: Elevated cerebrospinal fluid levels of substance P in patients with the fibro-mvalgia svndromc, Arthritis Rheum 1994:37: 1593-1601.
170. Vaeroy H, Helle R, Forre O, Kass E, Tercnius L: Elevated CSF levels of substance P and high incidence of Raynaud’s phenomenon in patients with fibromyalgia: New features for diagnosis, Pain 1988:32:21-26.
171. Vaeroy H, Nybcrg F, Tercnius L: No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Mct-enkephalin-Arg6-Phc7, Pain 1991:46:139-143.
172. Dubner R, Ruda MA: Activity dependent neuronal plasticity following tissue injury’ and inflammation, Trends Neurosci 1992; 15:96-103.
173. Mayer ML, Benvcnistc M, Patncau DK, Vylicky LJ: Pharmacological properties of NMDA receptors, Ann N Y Acad Sci 1992; 648:194-204.
174. Mogil JS, Flodman P, Spence MA, Sternberg WF, Kcsl B, Sadowski B, Licbcskind JC, Belknap JK: Oligogenic determination of morphine analgesic magnitude: A genetic analysis of selectively bred mouse lines, Be-hav Genet 1995:25:397-406.
175. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, Stewart KE, Alarcon GS, Mountz JD: Fibromyalgia in women, Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus arc associated with low pain threshold levels, Arthritis Rheum 1995:38: 926-938.
176. Elam M, Johansson G, Wallin BG: Do pa-tiens with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992;48:371-375.
177. Qiao ZG, Vaeroy H, Morkrid L: Electro-dermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests, J Rheumatol 1991; 18:1383-1389.
178. Clauw DJ, Radulovic D, Heshmat Y, Barbey JT: Heart rate variability as a measure of autonomic dysfunction in patients with fibromyalgia, Arthritis Rheum 1996:39(98):S276.
179. Clauiv DJ, Radulovic D, Antonetti D, Bagali R, Baraniuk J, Barbey JT: Till table testing in fibromyalgia, Arthritis Rheum 1996:39(95): S276.
180. Mayer EA, Ravbould HE: Role of visceral afferent mechanisms in functional bowel disorders, Gastroenterology 1990:99:1688-1704.
181. Buzzi M, Bonamini M, Ccrbo R: The anatomy and biochemistry of headache, Funct Neurol 1993:8:395-402.
182. Lynn R, Friedman L: Irritable bowel syndrome, N Engl J Med 1993:329:1940-1945.
183. Pogacnik T, Sega S, Pecnik B, Kiaula T: Autonomic function testing in patients with migraine, Headache 1993:33:545-550.
184. Aggarwal A, Cutis TF, Abell TL, Cardoso S, Famiioni B, Bremer J, Karas J: Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities, Gastroenterology 1994;106: 945-950.
185. McAllister C, Fielding JF: Patients with pulse rale changes in irritable bowel syndrome, Further evidence of altered autonomic function, J Clin Gastroenterol 1988;10:273-274.
186. Fukudo S, Suzuki J: Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome, Tohoku J Exp Med 1987; 151:373-385.
187. Pareja JA: Chronic paroxysmal hcmicrania: Dissociation of the pain and autonomic features, Headache 1995:35:11l-l13.
188. Zigelman M, Appel S, Davidovitch S, Kuritz-ky A, Zahavi I, Akselrod S: The effect of verapamil calcium antagonist on autonomic imbalance in migraine: Evaluation by spectral analysis of beat-to-beat heart rate fluctuations, Headache 1994:34:569-577.
189. Prusinski A, Trzos S, Rozcntryt P, Durko A, Kozlowski JW, Kozubski W, Sokolowski P: Studies of heart rhythm variability in migraine, Preliminary communication, Neurol NeurochirPol 1994;28:23-27.
190. Pogacnik T, Sega S, Pccnik B, Kiauta T: Autonomic function testing in patients with migraine, Headache 1993:33:545-550.
191. Appel S, Kuritzky A, Zahavi 1, Zigelman M, Akselrod S: Evidence for instability of the autonomic nervous system in patients with migraine headache, Headache 1992:32:10-17.
192. White AM, Stevens WH, Upton AR, O'byme PM, Collins SM: Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome, Gastroenterology 1991: 100:68-74.
193. Kellow JE, Eckcrslcy GM, Jones M: Enteric and central contributions to intestinal dvsmo-tility in irritable bowel syndrome, Dig Dis Sci 1992:37:168-174.
194. Whorwell PJ, Clouter C, Smith CL: Oesophageal motility in the irritable bowel syndrome, BMJ 282:1101-1102.
195. Whorwell PJ, Luplun EW, Erduran D, Wil-son K: Bladder smooth muscle dysfunction in patients with irritable bowel syndrome, Gut 1986:27:1014-1017.
196. Kellow JE, Phillips SF: Altered small bowel motility in irritable bowel syndrome is correlated with symptoms, Gastroenterology 1987; 92:1885-1893.